Search

Search Constraints

You searched for: Author/Creator Mori, Yoshiaki

Search Results

1. Characteristics and outcomes of patients with EGFR-mutation positive non-small-cell lung cancer receiving gefitinib beyond radiological progression. (3rd July 2018)

2. ChemInform Abstract: A Practical Regioselective Synthesis of Alkylthio‐ or Arylthioindoles Without the Use of Smelly Compounds such as Thiols. Issue 33 (25th July 2013)

3. Clinical Outcomes of Second‐Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study. (26th November 2019)

4. Macrophage inflammatory protein 1 alpha expression by synovial fluid neutrophils in rheumatoid arthritis. Issue 5 (1st May 1999)

5. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of japanese society of chemotherapy, the japanese association for infectious diseases, and the japanese society for clinical microbiology in 2016: General view of the pathogens' antibacterial susceptibility. Issue 9 (September 2020)

7. Phase II study of S-1 in patients with previously-treated invasive thymoma and thymic carcinoma: North Japan lung cancer study group trial 1203. (January 2020)

8. Randomized phase II trial comparing amrubicin with re-challenge of platinum doublet in patients with sensitive-relapsed small-cell lung cancer: North Japan Lung Cancer Study Group trial 0702. Issue 1 (July 2015)

9. Survival Analysis for Patients with ALK Rearrangement‐Positive Non‐Small Cell Lung Cancer and a Poor Performance Status Treated with Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401. (30th October 2019)

10. Treatment with immune checkpoint inhibitors after EGFR‐TKIs in EGFR‐mutated lung cancer. Issue 3 (13th December 2021)